ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of Drugs and Constipation in Nursing Homes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00849628
Recruitment Status : Completed
First Posted : February 24, 2009
Last Update Posted : July 19, 2016
Sponsor:
Collaborator:
Sykehuset Innlandet HF
Information provided by (Responsible Party):
Norwegian University of Science and Technology

Brief Summary:
The purpose of this study is to study factors (drugs, serum concentration of drugs, nutrition, physical activity, demographics, diseases etc.) related to constipation and diarrhea in nursing homes, and the effect of different laxative regimens.

Condition or disease
Constipation Diarrhea

Study Type : Observational
Actual Enrollment : 267 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Use of Drugs and Constipation in Nursing Homes
Study Start Date : June 2008
Actual Primary Completion Date : December 2009
Actual Study Completion Date : February 2010

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort
1
Constipation



Primary Outcome Measures :
  1. Prevalence of constipation [ Time Frame: One year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   60 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Residents in nursing homes
Criteria

Inclusion Criteria:

  • Above 60 years old
  • Stayed in nursing homes for more than 8 weeks
  • Informed consent

Exclusion Criteria:

  • Expected discharge within 2 weeks
  • Organic disorders causing constipation and diarrhea

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00849628


Locations
Norway
Innlandet Hospital Trust
Gjøvik, Oppland, Norway, 2819
Sponsors and Collaborators
Norwegian University of Science and Technology
Sykehuset Innlandet HF
Investigators
Principal Investigator: Per G Farup, PhD Sykehuset Innlandet HF

Publications of Results:
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00849628     History of Changes
Other Study ID Numbers: SI 150069-1
First Posted: February 24, 2009    Key Record Dates
Last Update Posted: July 19, 2016
Last Verified: July 2016

Keywords provided by Norwegian University of Science and Technology:
Aged
Polypharmacy
Adverse effects
Nursing homes

Additional relevant MeSH terms:
Constipation
Diarrhea
Signs and Symptoms, Digestive
Signs and Symptoms